Diversified Consumer Services
Company Overview of Johns Hopkins University
Johns Hopkins University is an educational institution offering undergraduate, graduate, part-time, summer, and distance education programs. The school of the university includes Krieger School of Arts and Sciences, Whiting School of Engineering, School of Professional Studies in Business and Education, School of Medicine, School of Nursing, Bloomberg School of Public Health, Nitze School of Advanced International Studies, The Peabody Institute, and Applied Physics Laboratory. Johns Hopkins University was established in 1876 and is based in Baltimore, Maryland. The university has endowment assets worth $2608.5 millions.
3400 North Charles Street
Baltimore, MD 21218-2608
Founded in 1876
Key Executives for Johns Hopkins University
Senior Associate Dean for Finance & Administration and Senior Associate Dean for Krieger School of Arts & Sciences
Executive Director of Communications and Public Affairs
Vice President of Communications and Public Affairs
Compensation as of Fiscal Year 2014.
Johns Hopkins University Key Developments
Tokai Pharmaceuticals, Inc. Enters into Worldwide License Agreement with the Johns Hopkins University
Jan 12 15
Tokai Pharmaceuticals Inc. announced that it has entered into an agreement with the Johns Hopkins University related to the development of a companion diagnostic to determine the AR-V7 status of patients with castration-resistant prostate cancer (CRPC) for use with the Company’s lead product, galeterone, which is in development for the treatment of AR-V7 positive metastatic CRPC. Under the agreement, the Company has obtained an exclusive, worldwide license from the Johns Hopkins University to patent applications and know-how covering an assay that has been used to determine the AR-V7 status of prostate cancer patients. AR-V7 positive prostate tumors express a truncated form of the androgen receptor (AR).
Good Start Genetics Announces Exclusive License Agreement with Johns Hopkins University for Key Assets in Preimplantion Genetic Screening
Dec 8 14
Good Start Genetics Inc. announced that it has entered into an exclusive license agreement with Johns Hopkins University (JHU) for FAST-SeqS, Fast Aneuploidy Screening Test-Sequencing System, invented by Drs. Bert Vogelstein, Ken Kinzler, Isaac Kinde, and Nickolas Papadopoulos of JHU. FAST-SeqS enables the screening of embryos for chromosome abnormalities prior to implantation in an in vitro fertilization setting. This practice, called preimplantation genetic screening, or PGS, increases the potential of transferring an embryo with the correct number of chromosomes and may ultimately increase pregnancy rates. FAST-SeqS may also have applications well beyond aneuploidy screening. FAST-SeqS is a simple, efficient method to count the number of chromosomes in an embryo. The technology uses a single primer pair to select and amplify distinct sections of the genome that occur on every chromosome. Existing PGS methods assess chromosome copy number, but are costly and often require lengthy turnarounds for results. The novel approach developed by Johns Hopkins researchers may help reduce costs associated with PGS and thereby make this testing more accessible to a wider range of patients. Over the past year, Good Start Genetics has developed the FAST-SeqS technology towards the development of a proprietary PGS assay.
Johns Hopkins Medicine Appoints Deborah Miller as Director of Cultural Transformation
Nov 20 14
A Member of Johns Hopkins Medicine (HCGH) announced the appointment of Deborah Miller as Director of Cultural Transformation, effective Dec. 1, 2014. As such, Miller will be responsible for working with staff at all levels of the organization to coordinate service excellence functions and activities leading toward creating an exemplary patient experience for every patient during every visit. With nine years of health care experience across three hospitals and in her third career. Her previous experiences include 10 years in commercial real estate and community development, and 15 years in the travel industry.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|